Alembic Pharmaceuticals Limited, a stalwart in the Indian pharmaceutical industry since its establishment in 1907, is excited to announce the successful raising of $14 million in its latest funding round. This significant investment underlines the confidence investors have in Alembic's robust market position and innovative capabilities. As a leader in the Macrolides segment of anti-infective drugs in India, Alembic is dedicated to not only maintaining its legacy but also expanding its reach and product offerings. The funding will primarily be allocated toward advancing research and development initiatives at its state-of-the-art Research Centre in Vadodara, which is crucial for the continuous innovation of high-quality pharmaceutical products. Additionally, this capital will facilitate enhancements in their production facilities located in Vadodara and Baddi, Himachal Pradesh, both of which boast US FDA-approved manufacturing capabilities. With the Vadodara plant hosting the largest fermentation capacity in India, Alembic aims to leverage this investment to further develop its manufacturing processes and streamline production to meet growing demand. By investing in cutting-edge technology and increasing production efficiency, Alembic Pharmaceuticals is poised to bolster its leadership position in the market while continuing to deliver safe and effective healthcare solutions to patients both in India and globally. This funding marks a pivotal moment for Alembic as it embarks on a journey towards greater innovation and sustainable growth, reaffirming its commitment to improving health outcomes through pharmaceutical excellence.
Pharmaceutical Powerhouse Alembic Secures $14 Million in Series A Funding for Expansion and Innovation
Get the full Alembic company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
OpenTrade
OpenTrade provides an institutional grade platform for yield products designed for fintechs and institutional investors across Web2 and Web3 ecosystems. Our offerings combines a technology platform with legal and operational frameworks and services that together support safe, compliant, and scalable yield products for the next generation of financial services & markets.
$17.0M Seed
today
Scout Space
Scout Space's mission is to enable our customers to perform complex missions and avoid threats by using on-board sensing, processing, and autonomous decision making. We are building next-generation sensor systems, autonomy software, and data platforms to enable cross-orbit intelligence and dynamic space operations. For more information, visit www.scout.space
$18.0M Series a
today
NSF Energy Storage Engine in Upstate NY
Accelerating Technology and Talent for a Made-in-America Energy Storage Future by leveraging Upstate New York’s premier universities, R&D ecosystem, state-of-art prototyping, and testbed infrastructure, Upstate NY Energy Storage Engine will catalyze critical innovation to enable the next-generation battery technologies and manufacturing methodologies, while training the future battery workforce.
$45.0M Grant
today
AI Library
AI Library's mission is to fully automate the software delivery lifecycle from planning to operating, not just coding. We do this by employing three agentic layers - Agent PLAN that helps to identify use cases, scoping, and generate timelines, deliverables, and KPIs. - Agent CODE to build the solution and integrate with existing systems and data. - Agent OPERATE to test, deploy into production, and monitor, optimize, and govern over time. Our key difference lies in the business model. AI Library prices by business outcomes, not code generated.
$560.0K Pre-seed
today
Kanvas Biosciences
We work to map the microbiome and illuminate interactions foundational to the health of humanity.
$48.0M Series a
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Scout Space United States | Series a | $18.0M | today |
| 2 | Kanvas Biosciences United States | Series a | $48.0M | today |
| 3 |  Bug Bounty Switzerland | Series a | $15.2M | today |
| 4 |  OnRe United Kingdom | Series a | $5.0M | today |
| 5 |  Dandelion Health United States | Series a | $14.0M | today |